File:Breast-and-other-cancer-dormancy-as-a-therapeutic-endpoint-speculative-recombinant-T-cell-receptor-1471-2407-10-251-S1.ogv

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Breast-and-other-cancer-dormancy-as-a-therapeutic-endpoint-speculative-recombinant-T-cell-receptor-1471-2407-10-251-S1.ogv(Ogg Theora video file, length 54 s, 640 × 480 pixels, 77 kbps, file size: 507 KB)

Captions

Captions

Add a one-line explanation of what this file represents

Summary[edit]

Description
English: Video clip. The body is constantly attacked by infections and defended by a collection of antibodies. The infections are represented by 'lightings' that have colours: light or dark blue and silver. The antibody filter has the same colours. The circle is the body containing a tube, which is the lymphoid vessel. The tissue cells (coloured red, yellow, white, brown and purple) are in the central upper part. T cells are located in the lymph node at the edge of the lymphoid vessel. A large APC is located in the lower part. Tissue cell-derived peptides determine TCR specificity. Colours of T cells designate the self pMHCs, which rescued them during positive selection. Complementary self pMHCs and TCRs have identical colours. For the sake of simplicity, in the animation the many different self pMHCs in a single cell are neglected. One T cell recognizes only one self pMHC. The animation shows how the whole system is capable of determining whether a given pMHC is self or non-self. An individual T cell is unable to make such a decision. Together, however, they can because there is a complementary TCR for every self pMHC in the immune system that recognizes an individual peptide fragment. The self pMHCs are presented, one by one, as they flow via the lymph into the lymph node. Eventually, all soluble self pMHCs are captured by complementary TCRs. In this way all tissue cells remain intact. Finally, a viral infection, designated by green colour, enters the body and infects a cell changing its self peptide into a foreign peptide (fpMHC). The soluble f pMHC molecule (the danger signal in the Homeostatic Role of T cells model) freely crosses the lymphoid tissue because no complementary TCR is present. Eventually, fpMHC is captured by an APC, which initiates 2 independent processes. Firstly, the APC activates cytotoxic T cells to locate and eliminate the infection. The T cells travel via the blood vessel into the tissues. In the meantime the virus infects other cells in the body and is also released to the environment represented by small green dots. Secondly, the APC initiates hypermutation in B cells represented by coloured dots at the lower right part of the screen. Eventually, the green colour will appear as a new B cell clone and also become part of the extended immune defence filter.
Date
Source Bakács T, Mehrishi J (2010). "Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?". BMC Cancer. DOI:10.1186/1471-2407-10-251. PMID 20525172. PMC: 2898695.
Author Bakács T, Mehrishi J
Permission
(Reusing this file)
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 2.0 Generic license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Provenance
InfoField
This file was transferred to Wikimedia Commons from PubMed Central by way of the Open Access Media Importer.
WikiProject Open Access
WikiProject Open Access

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current20:24, 20 November 201254 s, 640 × 480 (507 KB)Open Access Media Importer Bot (talk | contribs)Automatically uploaded media file from Open Access source. Please report problems or suggestions here.

There are no pages that use this file.

Transcode status

Update transcode status
Format Bitrate Download Status Encode time
VP9 480P 36 kbps Completed 05:58, 20 August 2018 9.0 s
Streaming 480p (VP9) 36 kbps Completed 12:25, 12 January 2024 0.0 s
VP9 360P 18 kbps Completed 05:58, 20 August 2018 8.0 s
Streaming 360p (VP9) 18 kbps Completed 12:40, 17 January 2024 1.0 s
VP9 240P 11 kbps Completed 05:58, 20 August 2018 6.0 s
Streaming 240p (VP9) 11 kbps Completed 11:07, 16 December 2023 1.0 s
WebM 360P 61 kbps Completed 13:31, 3 June 2013 16 s
Streaming 144p (MJPEG) 379 kbps Completed 08:29, 1 November 2023 2.0 s

Metadata